Signature	pVal	Genes
ACTACCT_MIR196A_MIR196B	6.1798310164e-06	HOXA7|HOXA5|HMGA2|HOXA1
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1	4.894739847e-05	IGF2BP2|HMGA2
BROWNE_HCMV_INFECTION_6HR_DN	0.000332206722368	HMGA2|HOXA11|HOXA10
CDP_02	9.74351011734e-05	HOXA7|HOXA2|HOXA11
CHOP_01	0.000978183787421	HOXA5|HOXA13|HOXA11
EFC_Q6	5.59977010192e-05	HOXA4|HOXA3|HOXA11|HOXA10
FOXJ2_01	0.000488806280829	HOXA7|HOXA11|HOXA10
FOXJ2_02	0.000928956397789	HOXA7|HOXA9|HOXA10
GCCNNNWTAAR_UNKNOWN	0.000236626791972	HOXA4|HMGA2|HOXA10
GRESHOCK_CANCER_COPY_NUMBER_UP	0.000141805742656	HOXA13|HMGA2|HOXA9|HOXA11
GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN	0.000480829638839	HOXA7|HOXA9|HOXA10
GSE17721_CTRL_VS_CPG_8H_BMDC_DN	0.000618837269805	HOXA3|HOXA13|HOXA9
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP	0.000609549786571	HOXA5|IGF2BP2|HMGA2
GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN	0.000564455088742	HOXA7|HOXA11|HOXA1
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP	0.000488806280829	FOXG1|HOXA5|HOXA11
HNF3B_01	2.75620286633e-05	HOXA7|FOXG1|HOXA4|HOXA11
HNF4_Q6	2.02143501218e-06	FOXG1|HOXA3|HOXA5|HOXA11|HOXA10
Human Leukemia_Chiaretti10_38genes (20418243-SuppTable1b)	0.000341465436736	HOXA7|HOXA5
Human Leukemia_Krivtsov08_50genes (18977325-Figure5e)	0.000721718422398	HOXA5|HOXA9
Human Leukemia_Tsai08_30genes (18842155-Table2)	0.000186561142332	HOXA9|HOXA10
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	0.000192403396262	IGF2BP2|HOXA4|HMGA2|GNAS-AS1|HOXA9
LEE_INTRATHYMIC_T_PROGENITOR	0.000113115357169	SKAP2|HOXA9
LI_WILMS_TUMOR	7.30762824485e-09	FOXG1|HMGA2|HOXA9|HOXA11
MATZUK_IMPLANTATION_AND_UTERINE	0.000155014290743	HOXA11|HOXA10
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29	3.24888441066e-08	HOXA13|HOXA9|HOXA11
SCHRAETS_MLL_TARGETS_UP	0.000436021049144	FOXG1|HOXA1
SMAD4_Q6	0.000941111402864	HOXA3|HOXA9|HOXA10
SREBP1_01	0.00037783767245	HOXA7|HOXA2|HOXA11
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	6.73001859829e-07	HOXA5|HOXA4|HOXA3|HOXA9
USF_Q6_01	4.16960159626e-05	HOXA7|HOXA3|HOXA9|HOXA1
VALK_AML_WITH_CEBPA	0.000461429361261	IGF2BP2|HOXA9
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	0.000284612662829	HOXA4|HOXA3|HOXA1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	5.58821058101e-07	HOXA11-AS|HOXA11|HOXA10
development of primary male sexual characteristics [GoID:GO:0046546; evidenceTypes:IBA|IDA|IEA|IEP|IGI|IMP|ISS|TAS]	0.000198675586837	HOXA9|HOXA11|HOXA10
development of primary sexual characteristics [GoID:GO:0045137; evidenceTypes:IBA|IDA|IEA|IEP|IGI|IMP|ISS|NAS|TAS]	0.000737441098999	HOXA9|HOXA11|HOXA10
gonad development [GoID:GO:0008406; evidenceTypes:IBA|IDA|IEA|IEP|IGI|IMP|ISS|NAS|TAS]	0.000686400772297	HOXA9|HOXA11|HOXA10
male gonad development [GoID:GO:0008584; evidenceTypes:IBA|IDA|IEA|IEP|IGI|IMP|ISS|TAS]	0.000194231429412	HOXA9|HOXA11|HOXA10
male sex differentiation [GoID:GO:0046661; evidenceTypes:IBA|IDA|IEA|IEP|IGI|IMP|ISS|NAS|TAS]	0.000307814209063	HOXA9|HOXA11|HOXA10
mesodermal cell differentiation [GoID:GO:0048333; evidenceTypes:IDA|IEA|IEP|IMP|ISS|TAS]	0.000341465436736	HMGA2|HOXA11
thyroid gland development [GoID:GO:0030878; evidenceTypes:IEA|IEP|IMP|ISS]	0.000186561142332	HOXA5|HOXA3
uterus development [GoID:GO:0060065; evidenceTypes:IEA|IMP|ISS]	5.58821058101e-07	HOXA9|HOXA11|HOXA10
